ID SYL_ANAMM Reviewed; 829 AA. AC Q5PB38; DT 20-MAY-2008, integrated into UniProtKB/Swiss-Prot. DT 04-JAN-2005, sequence version 1. DT 27-MAR-2024, entry version 122. DE RecName: Full=Leucine--tRNA ligase {ECO:0000255|HAMAP-Rule:MF_00049}; DE EC=6.1.1.4 {ECO:0000255|HAMAP-Rule:MF_00049}; DE AltName: Full=Leucyl-tRNA synthetase {ECO:0000255|HAMAP-Rule:MF_00049}; DE Short=LeuRS {ECO:0000255|HAMAP-Rule:MF_00049}; GN Name=leuS {ECO:0000255|HAMAP-Rule:MF_00049}; OrderedLocusNames=AM446; OS Anaplasma marginale (strain St. Maries). OC Bacteria; Pseudomonadota; Alphaproteobacteria; Rickettsiales; OC Anaplasmataceae; Anaplasma. OX NCBI_TaxID=234826; RN [1] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RC STRAIN=St. Maries; RX PubMed=15618402; DOI=10.1073/pnas.0406656102; RA Brayton K.A., Kappmeyer L.S., Herndon D.R., Dark M.J., Tibbals D.L., RA Palmer G.H., McGuire T.C., Knowles D.P. Jr.; RT "Complete genome sequencing of Anaplasma marginale reveals that the surface RT is skewed to two superfamilies of outer membrane proteins."; RL Proc. Natl. Acad. Sci. U.S.A. 102:844-849(2005). CC -!- CATALYTIC ACTIVITY: CC Reaction=ATP + L-leucine + tRNA(Leu) = AMP + diphosphate + L-leucyl- CC tRNA(Leu); Xref=Rhea:RHEA:11688, Rhea:RHEA-COMP:9613, Rhea:RHEA- CC COMP:9622, ChEBI:CHEBI:30616, ChEBI:CHEBI:33019, ChEBI:CHEBI:57427, CC ChEBI:CHEBI:78442, ChEBI:CHEBI:78494, ChEBI:CHEBI:456215; EC=6.1.1.4; CC Evidence={ECO:0000255|HAMAP-Rule:MF_00049}; CC -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000255|HAMAP-Rule:MF_00049}. CC -!- SIMILARITY: Belongs to the class-I aminoacyl-tRNA synthetase family. CC {ECO:0000255|HAMAP-Rule:MF_00049}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; CP000030; AAV86492.1; -; Genomic_DNA. DR AlphaFoldDB; Q5PB38; -. DR SMR; Q5PB38; -. DR KEGG; ama:AM446; -. DR HOGENOM; CLU_004427_0_0_5; -. DR GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell. DR GO; GO:0002161; F:aminoacyl-tRNA editing activity; IEA:InterPro. DR GO; GO:0005524; F:ATP binding; IEA:UniProtKB-UniRule. DR GO; GO:0004823; F:leucine-tRNA ligase activity; IEA:UniProtKB-UniRule. DR GO; GO:0006429; P:leucyl-tRNA aminoacylation; IEA:UniProtKB-UniRule. DR CDD; cd07958; Anticodon_Ia_Leu_BEm; 1. DR CDD; cd00812; LeuRS_core; 1. DR Gene3D; 3.40.50.620; HUPs; 2. DR HAMAP; MF_00049_B; Leu_tRNA_synth_B; 1. DR InterPro; IPR001412; aa-tRNA-synth_I_CS. DR InterPro; IPR002300; aa-tRNA-synth_Ia. DR InterPro; IPR002302; Leu-tRNA-ligase. DR InterPro; IPR025709; Leu_tRNA-synth_edit. DR InterPro; IPR013155; M/V/L/I-tRNA-synth_anticd-bd. DR InterPro; IPR015413; Methionyl/Leucyl_tRNA_Synth. DR InterPro; IPR014729; Rossmann-like_a/b/a_fold. DR InterPro; IPR009080; tRNAsynth_Ia_anticodon-bd. DR InterPro; IPR009008; Val/Leu/Ile-tRNA-synth_edit. DR NCBIfam; TIGR00396; leuS_bact; 1. DR PANTHER; PTHR43740:SF2; LEUCINE--TRNA LIGASE, MITOCHONDRIAL; 1. DR PANTHER; PTHR43740; LEUCYL-TRNA SYNTHETASE; 1. DR Pfam; PF08264; Anticodon_1; 1. DR Pfam; PF00133; tRNA-synt_1; 2. DR Pfam; PF13603; tRNA-synt_1_2; 1. DR Pfam; PF09334; tRNA-synt_1g; 1. DR PRINTS; PR00985; TRNASYNTHLEU. DR SUPFAM; SSF47323; Anticodon-binding domain of a subclass of class I aminoacyl-tRNA synthetases; 1. DR SUPFAM; SSF52374; Nucleotidylyl transferase; 1. DR SUPFAM; SSF50677; ValRS/IleRS/LeuRS editing domain; 1. DR PROSITE; PS00178; AA_TRNA_LIGASE_I; 1. PE 3: Inferred from homology; KW Aminoacyl-tRNA synthetase; ATP-binding; Cytoplasm; Ligase; KW Nucleotide-binding; Protein biosynthesis. FT CHAIN 1..829 FT /note="Leucine--tRNA ligase" FT /id="PRO_0000334727" FT MOTIF 40..50 FT /note="'HIGH' region" FT MOTIF 594..598 FT /note="'KMSKS' region" FT BINDING 597 FT /ligand="ATP" FT /ligand_id="ChEBI:CHEBI:30616" FT /evidence="ECO:0000255|HAMAP-Rule:MF_00049" SQ SEQUENCE 829 AA; 94109 MW; E5881D97AB91F66E CRC64; MEFFGMGYNF KLVEQEIQKR WDFKIAGNDG INCYVLGMFP YPSGNIHMGH IRNYTIGDVI ARYKRAHGLK VLHPIGWDAF GLPAENAALS YGVNPAVWTE RNIESMRKQL KSIGISYNWD RELATCKEDY YKHEQAFFLD FLQQGLAYRK ESWVNWDPVD NTVLANEQVV DGRGWRSGAK IERRKLSQWF LKITDFADSL LDGLKTLDGW PEKVKLMQER WIGKTEGVIL EFATSCGQKL EVFSTMPHML FGASFCAVSA EHPILRHVTD EAFSARVRGI IECSGDEEKQ KIGADTGLFA THPLLDRKLP IYAANYVLSE YGTGAVFGCP AHDQRDFEFA VAHGLDIYQV VFPDDGVQYD LQKEAYSGDG TYRNSEFLNG LRVDAARNAM IQKLESMGGC RRVTNYRLHD WGISRQRYWG CPIPVVHCEK CGIVPVDRQD LPISLPEEVD FSRGGNPLDH HPTWKHVQCP KCQSSAQRET DTFDTFFESS WYFAAFCSEQ GGINAADCNK LLPVDYYIGG VEHAVLHLLY ARFFCRALKK CGHLAVEEPF RNLITQGMVC HSVYRDAAGN YLFPEDAQRM IRDGEAVQRG KVEKMSKSKK NVVDPSHIIK KYGADTVRLF MLSDTPPERD IEWSDVGVEG AWRYLERLWR LFEDNSSIGA DFDTADVKAE DRVYLSGIHK LLRGLSADME HCRLNCAVAK FREMSNTVFE MVKCGVSQQV INESVCILLR VMEPFIPHIA EKLWERIGGE GMLCNRQWPS AREDLLTEDL VTIAVQVNGK LCSTLKVGAQ CDGEEVKAEA LKVAQRKLGD KEVRNIYFVP GRVVNIVTK //